Showing results (1111-1120 of 1,161) with videos related to

Sort By:
Pageof 117
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
Journal of Autoimmunity|October 2, 2019
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factorThibault Maillet, Tiphaine Goletto, Guillaume Beltramo, et al.
European Journal of Immunology|March 19, 2013
IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infectionRodrigo Guabiraba, Anne-Gaëlle Besnard, Rafael E Marques, et al.
ACS Chemical Biology|August 18, 2020
PEARL-seq: A Photoaffinity Platform for the Analysis of Small Molecule-RNA InteractionsHerschel Mukherjee, J Craig Blain, Lee E Vandivier, et al.
Nature Communications|October 27, 2024
Atypical rhizobia trigger nodulation and pathogenesis on the same legume hostsKévin Magne, Sophie Massot, Tifaine Folletti, et al.
The Plant Cell|August 9, 2024
Alternating between even and odd ploidy levels switches on and off the recombination control, even near the centromeresFranz Boideau, Virginie Huteau, Loeiz Maillet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
Future Oncology (London, England)|January 13, 2017
EVESOR, a model-based, multiparameter, Phase I trial to optimize the benefit/toxicity ratio of everolimus and sorafenibMévidette El-Madani, Olivier Colomban, Michel Tod, et al.
Joint Bone Spine|September 15, 2020
Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritisJérémie Sellam, Alice Courties, Florent Eymard, et al.
Clinical Pharmacokinetics|July 4, 2024
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI TrialJérôme Alexandre, Stephane Oudard, Lisa Golmard, et al.
Pageof 117